first of all, hats off to @ADC_BMJ to publishing what is essentially an (important) negative finding & for making it free to read at no cost to the authors
Scotland should have the same, or join England's @scotgov 14/n
2) interventions implemented to reduced SARS-CoV-2 transmission have had a dramatic reduction on the burden of childhood morbidity
what can we learn from this in terms of reducing risk to, in particular infants, of hospitalisation? 15/n
we managed to crush the curve for COVID-19 (at least initially) and (so far) have crushed the curve for RSV this winter @PHE_uk 16/n
couldn't we do this every year by washing our hands, minimising social contacts, and paying attention to infection risk in babies? 17/n
3) a constant tension in clinical research looking at rare events is balancing patient confidentiality with public good
as clinicians we rightly prize patient autonomy
however, in this pandemic in the UK we have privileged individual rights above societal good 18/n
successfully eliminating COVID-19 has required restricting people's right to free movement and to privacy (in Taiwan, NZ, Australia) 19/n
of course there is the risk of mission creep
but I believe we should think about ways to make detailed data on important issues like child deaths and hospitalisations available quickly and openly 20/n
so that clinicians, researchers, government and probably most importantly parents can contribute towards discussions on making quick and decisive (if not perfect @DrMikeRyan) decisions 21/n
to conclude
let's learn from this pandemic
let's use what we've learnt to protect the most vulnerable in our society, but also our future : children and young people
(END)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
at the start of this pandemic, the WHO and others advised that restricting international travel was not an effective way to stop the spread of SARS-CoV-2 who.int/news-room/arti… 2/n
BNT162b2 is an mRNA vaccine. Although the SARS-CoV-2 vaccines are the first of this family to be licensed, they have been studied for many years in influenza, Zika, rabies and RSV @CDCgov
the mRNA in the vaccine contains nucleoside modifications to make it more stable, and is packaged in lipid nanoparticles so that the the mRNA is taken up by cells.